These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9868710)

  • 1. Limited value of fluorine-18-fluorodeoxyglucose PET for the differential diagnosis of focal liver lesions in patients with chronic hepatitis C virus infection.
    Schröder O; Trojan J; Zeuzem S; Baum RP
    Nuklearmedizin; 1998; 37(8):279-85. PubMed ID: 9868710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma.
    Trojan J; Schroeder O; Raedle J; Baum RP; Herrmann G; Jacobi V; Zeuzem S
    Am J Gastroenterol; 1999 Nov; 94(11):3314-9. PubMed ID: 10566736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limited value of 18F-2-deoxyglucose positron emission tomography to detect hepatocellular carcinoma in hepatitis B virus carriers.
    Jeng LB; Changlai SP; Shen YY; Lin CC; Tsai CH; Kao CH
    Hepatogastroenterology; 2003; 50(54):2154-6. PubMed ID: 14696485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of [18F]fluorodeoxyglucose positron emission tomography imaging in the evaluation of hepatocellular carcinoma.
    Wudel LJ; Delbeke D; Morris D; Rice M; Washington MK; Shyr Y; Pinson CW; Chapman WC
    Am Surg; 2003 Feb; 69(2):117-24; discussion 124-6. PubMed ID: 12641351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of FDG-PET in the evaluation and staging of hepatocellular carcinoma with comparison of tumor size, AFP level, and histologic grade.
    Wolfort RM; Papillion PW; Turnage RH; Lillien DL; Ramaswamy MR; Zibari GB
    Int Surg; 2010; 95(1):67-75. PubMed ID: 20480845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early diagnosis of recurrent hepatocellular carcinoma with 18F-FDG PET after radiofrequency ablation therapy.
    Paudyal B; Oriuchi N; Paudyal P; Tsushima Y; Iida Y; Higuchi T; Hanaoka H; Miyakubo M; Takano A; Ishikita T; Endo K
    Oncol Rep; 2007 Dec; 18(6):1469-73. PubMed ID: 17982632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Malignant tumor with false negative 18F-FDG PET image].
    Dong MJ; Lin XT; Zhao J; Guan YH; Zuo CT; Chen X; Dai JZ; Jiang BD
    Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):713-7. PubMed ID: 17274383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDG PET/CT early dynamic blood flow and late standardized uptake value determination in hepatocellular carcinoma.
    Bernstine H; Braun M; Yefremov N; Lamash Y; Carmi R; Stern D; Steinmetz A; Sosna J; Groshar D
    Radiology; 2011 Aug; 260(2):503-10. PubMed ID: 21555347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Value of 18F-FDG PET/CT in Detecting Adrenal Metastasis in Patients with Hepatocellular Carcinoma.
    Lin Y; Jeng LB; Wang HY; Tsai SC; Lin WY; Kao CH
    Technol Cancer Res Treat; 2015 Oct; 14(5):593-9. PubMed ID: 24945368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 11C-acetate PET imaging in hepatocellular carcinoma and other liver masses.
    Ho CL; Yu SC; Yeung DW
    J Nucl Med; 2003 Feb; 44(2):213-21. PubMed ID: 12571212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of fluorine-18-FDG-PET to monitor hepatocellular carcinoma after interventional therapy.
    Torizuka T; Tamaki N; Inokuma T; Magata Y; Yonekura Y; Tanaka A; Yamaoka Y; Yamamoto K; Konishi J
    J Nucl Med; 1994 Dec; 35(12):1965-9. PubMed ID: 7989978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis of Hepatocellular Carcinoma Using C11 Choline PET/CT: Comparison with F18 FDG, ContrastEnhanced MRI and MDCT.
    Chotipanich C; Kunawudhi A; Promteangtrong C; Tungsuppawattanakit P; Sricharunrat T; Wongsa P
    Asian Pac J Cancer Prev; 2016; 17(7):3569-73. PubMed ID: 27510010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose in the diagnosis of liver tumors.
    Iwata Y; Shiomi S; Sasaki N; Jomura H; Nishiguchi S; Seki S; Kawabe J; Ochi H
    Ann Nucl Med; 2000 Apr; 14(2):121-6. PubMed ID: 10830530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG-PET.
    Torizuka T; Tamaki N; Inokuma T; Magata Y; Sasayama S; Yonekura Y; Tanaka A; Yamaoka Y; Yamamoto K; Konishi J
    J Nucl Med; 1995 Oct; 36(10):1811-7. PubMed ID: 7562048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of hepatocellular carcinoma using 11C-choline PET: comparison with 18F-FDG PET.
    Yamamoto Y; Nishiyama Y; Kameyama R; Okano K; Kashiwagi H; Deguchi A; Kaji M; Ohkawa M
    J Nucl Med; 2008 Aug; 49(8):1245-8. PubMed ID: 18632827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis of liver nodules observed in chronic liver disease patients during ultrasound screening for early detection of hepatocellular carcinoma.
    Caturelli E; Bartolucci F; Biasini E; Vigliotti ML; Andriulli A; Siena DA; Attino V; Bisceglia M
    Am J Gastroenterol; 2002 Feb; 97(2):397-405. PubMed ID: 11866279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PET/CT characteristics of isolated bone metastases in hepatocellular carcinoma.
    Ho CL; Chen S; Cheng TK; Leung YL
    Radiology; 2011 Feb; 258(2):515-23. PubMed ID: 21062922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Focal liver lesions in non-Hodgkin's lymphoma: investigation of their prevalence, clinical significance and the role of Hepatitis C virus infection.
    Civardi G; Vallisa D; Bertè R; Lazzaro A; Moroni CF; Cavanna L
    Eur J Cancer; 2002 Dec; 38(18):2382-7. PubMed ID: 12460782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case report of surgical treatment for hepatocellular carcinoma with a Hugely swollen lymph node that showed high FDG uptake].
    Hatano H; Masuike Y; Noda T; Tanida T; Oshima K; Komori T; Imamura H; Morita S; Iwazawa T; Akagi K; Yasumoto T; Adachi S; Dono K
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):2133-5. PubMed ID: 25731447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of liver metastases from pancreatic cancer using FDG PET.
    Fröhlich A; Diederichs CG; Staib L; Vogel J; Beger HG; Reske SN
    J Nucl Med; 1999 Feb; 40(2):250-5. PubMed ID: 10025831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.